


Healthcare News Roundup: FDA
HSMN NewsFeed - 22 Apr 2021
Getinge receives US FDA 510(k) clearance for three products, expanding the Servo ventilator platform
Getinge receives US FDA 510(k) clearance for three products, expanding the Servo ventilator platform
HSMN NewsFeed - 21 Apr 2021
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
HSMN NewsFeed - 19 Apr 2021
Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS
Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS
HSMN NewsFeed - 7 Apr 2021
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
FDA Approves Bausch & Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
HSMN NewsFeed - 5 Apr 2021
IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
HSMN NewsFeed - 18 Mar 2021
Boston Scientific Receives FDA Approval for TheraSphere(TM) Y-90 Glass Microspheres
Boston Scientific Receives FDA Approval for TheraSphere(TM) Y-90 Glass Microspheres
HSMN NewsFeed - 16 Mar 2021
Imbio Receives FDA 510(k) Clearance for New Cardiothoracic Imaging Algorithm
Imbio Receives FDA 510(k) Clearance for New Cardiothoracic Imaging Algorithm
HSMN NewsFeed - 11 Mar 2021
Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG
Qardio Announces FDA Clearance for QardioCore, a self-fit continuous ambulatory ECG to view and annotate ECG
HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
HSMN NewsFeed - 10 Mar 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
HSMN NewsFeed - 3 Mar 2021
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
Creative Medical Technology Holdings Provides Update on ImmCelz(R) FDA Application
